Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 3	2026-08-13		NCT06712888

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital of Guizhou Medical University	3
Affiliated Hospital of Guangdong Medical University	27
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center	23
First Affiliated Hospital of Guangxi Medical University	96
Fujian Cancer Hospital	114
Guangxi Medical University Cancer Center	1
Hunan Cancer Hospital	66
Sichuan Cancer Hospital and Research Institute	64
Sun Yat-sen University	606
The University of Hong Kong-Shenzhen Hospital	27

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Guangdong Medical University	Zhanjiang	China	14
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center	Shenzhen	China	4
First Affiliated Hospital of Guangxi Medical University	Nanning	China	5
Fujian Cancer Hospital	Fuzhou	China	55
Guangxi Medical University Cancer Center	Nanning	China	2
Hunan Cancer Hospital	Changsha	China	87
Sichuan Cancer Hospital	Chengdu	China	30
Sun Yat-sen University Cancer Center	Guangzhou	China	315
The Affiliated Cancer Hosipital of Guizhou Meidical University	Guiyang	China	1
The University of Hong Kong-Shenzhen Hospital	Shenzhen	China	3